Webinars


Efecto del precondicionamiento isquemico en modelos experimentales microquirurgicos de isquemia–reperfusion intestinal / Effect of Ischemic Preconditioning in Experimental-Microsurgical Models of Intestinal Ischemia-Reperfusion

62.1 - Efecto del precondicionamiento isquemico en modelos experimentales microquirurgicos de isquemia–reperfusion intestinal / Effect of Ischemic Preconditioning in Experimental-Microsurgical Models of Intestinal Ischemia-Reperfusion

Presenter: Pablo, Stringa, La Plata, Argentina
Authors: Pablo Stringa


Overview:

La injuria por isquemia reperfusión (IIR) es una reacción inflamatoria con alta morbi-mortalidad en pacientes sometidos a trasplante intestinal o que sufren diversas enfermedades intestinales. Pese a que se postulan varias estrategias para atenuar la IIR, no existe consenso sobre cuál es la más adecuada. Entre ellas, el Precondicionamiento isquémico aparece como un tratamiento promisorio capaz de disminuir la IIR y por tal motivo es objeto de estudio.

Ischemia-reperfusion injury (IRI) is an inflammatory reaction with high morbidity and mortality in patients undergoing intestinal transplantation or suffering from intestinal diseases. Therefore, establishing strategies to mitigate IRI are major objectives in surgical fields including transplantation. Ischemic preconditioning appears as a promising treatment able to decrease IIR. For this reason it is the object of our study.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi